 SAN CARLOS, Calif., Aug. 12, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2021 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2021 with the Securities and Exchange Commission. 